Table 2 Summary of the percentage of hypomethylated CpGs relative to all the CpGs represented in the mouse array in brain and liver from Dnmt3a1−/− and Dnmt3a2−/− mice
From: Dnmt3a2 expression during embryonic development is required for phenotypic stability
Hypomethylation % | E15.5 | PD 21 |
|---|---|---|
Dnmt3a1−/− brain | 0.041% | 26% |
Dnmt3a1−/− liver | 0.018% | 12% |
Dnmt3a2−/− brain | 8.1% | 1.3% |
Dnmt3a2−/− liver | 3.8% | 1.8% |